Changes in HbA1c and Weight, and Treatment Persistence, Over the 18 Months Following Initiation of Second-Line Therapy in Patients With Type 2 Diabetes: Results From the United Kingdom Clinical Practice Research Datalink
BMC Medicine - United Kingdom
doi 10.1186/s12916-018-1085-8
Full Text
Open PDFAbstract
Available in full text
Categories
Date
July 16, 2018
Authors
Publisher
Springer Science and Business Media LLC